Delayed Dosing of Oral Rotavirus Vaccine Demonstrates Decreased Risk of Rotavirus Gastroenteritis Associated With Serum Zinc: A Randomized Controlled Trial | Zendy

E. Ross Colgate | Zendy; Rashidul Haque | Zendy; Dorothy M. Dickson | Zendy; Marya P. Carmolli | Zendy; Josyf C. Mychaleckyj | Zendy; Uma Nayak | Zendy; Firdausi Qadri | Zendy; Masud Alam | Zendy; Mary Claire Walsh | Zendy; Sean A. Diehl | Zendy; Khalequ Zaman | Zendy; William A. Petri | Zendy; Beth D. Kirkpatrick | Zendy

Open Access

Delayed Dosing of Oral Rotavirus Vaccine Demonstrates Decreased Risk of Rotavirus Gastroenteritis Associated With Serum Zinc: A Randomized Controlled Trial

Author(s) -

E. Ross Colgate,

Rashidul Haque,

Dorothy M. Dickson,

Marya P. Carmolli,

Josyf C. Mychaleckyj,

Uma Nayak,

Firdausi Qadri,

Masud Alam,

Mary Claire Walsh,

Sean A. Diehl,

Khalequ Zaman,

William A. Petri,

Beth D. Kirkpatrick

Publication year - 2016

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/ciw346

Subject(s) - medicine , rotavirus , odds ratio , diarrhea , pediatrics , rotavirus vaccine , incidence (geometry) , randomized controlled trial , confidence interval , vaccine efficacy , vaccination , immunology , physics , optics

Rotavirus is the world's leading cause of childhood diarrheal death. Despite successes, oral rotavirus vaccines are less effective in developing countries. In an urban slum of Dhaka, we performed active diarrhea surveillance to evaluate monovalent G1P[8] rotavirus vaccine (RV1) efficacy and understand variables contributing to risk of rotavirus diarrhea (RVD).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research